Newsletter | April 14, 2026

04.14.26 -- Manipulating Costs And Technology Prices In Clinical Research

CLINICAL TRIAL TECHNOLOGY

RWE Is Ready — Decision Making For Pharmaceuticals Isn't

Gorana Capkun of Merck, KGaA, Darmstadt, Germany discusses the growing role of real-world evidence in clinical trials, highlighting a gap between regulatory momentum and pharma adoption— and the challenge of turning data into better decisions.

Positioning Technology Costs To Secure Sponsor Reimbursement

Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.

eCOA Standards And KPIs To Include In Your Next RFI

Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.

Reduce The Impact Of Change Orders With This Commercial Framework

A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.

Embracing Integration And Relieving The Burden On Study Teams

Intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Tuesday edition of the Clinical Leader newsletter, focusing on Clinical Trial Technology. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: